The OSA cell line used for this particular xenograft had high expression of PDGFR, c‐Kit and VEGFR2 and, as a result, it has been suggested that toceranib phosphate is more effective in tumors with high expression of these receptors. The gene discussed is PDGFRB; the disease is obstructive sleep apnea syndrome.